An insistent buzzing at sunset followed by itchy, spotted legs. Here in Denmark, mosquitoes are mostly an annoying—but ...

Researchers are reporting two promising approaches to counteract malaria's growing drug resistance. Switzerland-based Novartis has released results for a new experimental drug called GanLum.

A single dose of a four-drug combination therapy for uncomplicated malaria was just as effective as the multi-day standard of ...

Global vaccine alliance Gavi and its partner Unicef will pay 25% less for a new malaria vaccine made by the Serum Institute ...

Ines’ research takes a multidisciplinary approach to understand the spread, evolution, and molecular interaction of the ...

Edson Mwebesa, Fellow at the Wits-based Sub-Saharan Africa Advanced Consortium for Biostatistics (SSACAB), knows children who ...

Gavi and UNICEF's new agreement aims to make malaria vaccines more affordable, saving $90 million and benefiting millions of ...

With victims numbering in the millions, malaria is an infectious disease caused by the bite of a mosquito carrying the ...

The first new malaria treatment in decades holds promise against rising drug resistance after Swiss drugmaker Novartis ...

For the past quarter-century, the gold standard malaria treatment has been artemisinin combination therapies (ACTs). Yet ...

Patronus Biotech receives grant to evaluate a novel malaria vaccine and adjuvant to support affordable access and use in ...

A fungal infection solution could help eliminate up to 86% of malaria-carrying mosquitoes, offering a powerful new tool in ...